Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Endothelin receptor antagonists for pulmonary arterial hypertension

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD004434.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2004see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Vías respiratorias

Copyright:
  1. Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Chao Liu

    Correspondencia a: The First Hospital of Hebei Medical University, Shijiazhuang, China

    [email protected]

  • Junmin Chen

    The first Affiliated Hospital of Fujian Medical University, Fuzhou City, China

Contributions of authors

CL: Protocol initiation, study assessment, data extraction and entry, interpretation and write‐up. Overall responsibility for maintaining the review.
JC: Protocol developmet, study assessment, data extraction, interpretation and write‐up

Declarations of interest

This systematic review was supported by a grant from WHO while CL in residence at the Australasian Cochrane Centre. The reviewers participated in training from the Australasian Cochrane Centre (including the Cochrane Review Completion Program) while in Australia.

Acknowledgements

We wish to thank the editorial staff of the Cochrane Airways group for their support. We would also like to thank the support from Dr Sally Green, Ms Denise O'Connor, Mr Steve McDonald, Janet Piehl and other staff in the Australasian Cochrane Centre for their supervision and technical assistance in the progress of writing this review. We also are grateful to Dr Elmer Villanueva for excellent statistical assistance.

Version history

Published

Title

Stage

Authors

Version

2021 Mar 25

Endothelin receptor antagonists for pulmonary arterial hypertension

Review

Chao Liu, Junmin Chen, Yanqiu Gao, Bao Deng, Kunshen Liu

https://doi.org/10.1002/14651858.CD004434.pub6

2013 Feb 28

Endothelin receptor antagonists for pulmonary arterial hypertension

Review

Chao Liu, Junmin Chen, Yanqiu Gao, Bao Deng, Kunshen Liu

https://doi.org/10.1002/14651858.CD004434.pub5

2009 Jul 08

Endothelin receptor antagonists for pulmonary arterial hypertension

Review

Chao Liu, Junmin Chen, Yanqiu Gao, Bao Deng, Kunshen Liu

https://doi.org/10.1002/14651858.CD004434.pub4

2006 Jul 19

Endothelin receptor antagonists for pulmonary arterial hypertension

Review

Chao Liu, Junmin Chen

https://doi.org/10.1002/14651858.CD004434.pub3

2004 Oct 18

Endothelin receptor antagonists for pulmonary arterial hypertension

Review

Chao Liu, Junmin Chen

https://doi.org/10.1002/14651858.CD004434.pub2

2003 Jul 21

Endothelin receptor antagonists for pulmonary arterial hypertension

Protocol

Chao Liu, Junmin Chen

https://doi.org/10.1002/14651858.CD004434

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.